[News] EU cancer drug leaflets contain insufficient information

August, 08, 2024 | Select Oncology Journal Articles

Patient information concerning the benefits and related uncertainties of anticancer drugs in Europe is absent or inadequate, according to a study.

For Additional News from OncWeekly – Your Front Row Seat To The Future of Cancer Care –

Advertisement

LATEST

Impact of PORT on Outcomes in Advanced TESCC

Impact of PORT on Outcomes in Advanced TESCC

Sep 30, 2024

BTN3A1 Drives Vγ9Vδ2 T Cell Exhaustion in Cervical Cancer

BTN3A1 Drives Vγ9Vδ2 T Cell Exhaustion in Cervical Cancer

Sep 30, 2024

Inhibition of NF-κB/HIF-1α Pathway by Tyrosol in CRC

Inhibition of NF-κB/HIF-1α Pathway by Tyrosol in CRC

Sep 30, 2024

Nomilin Targets PI3K/Akt Pathway in TNBC

Nomilin Targets PI3K/Akt Pathway in TNBC

Sep 30, 2024

Advertisement

Sign up for our emails

Trusted insights straight to your inbox and get the latest updates from OncWeekly

Newsletter

Privacy Policy